A
10b5-1 Plan
$ Value
$25K
Shares
269
Price
$94
Filed
Apr 2
Insider
Name
HARRIGAN EDMUND
Title
—
CIK
0001177917
Roles
Director
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,122
Footnotes
Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested. | This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Filing Info
HARRIGAN EDMUND's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | INCY | A | $25K |
| 2025-06-30 | INCY | A | $25K |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-05-29 | ACAD | M | — |
| 2025-05-29 | ACAD | M | $0 |
| 2025-05-29 | ACAD | A | $0 |
| 2025-05-29 | ACAD | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |